Nisa Investment Advisors, LLC Tricida, Inc. Transaction History

Nisa Investment Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 18, 2021	SELL	$3.56 - $4.64 $1,424 - $1,855	-400 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$3.95 - $5.41 $395 - $541	100 Added 33.33%	400 $2,000
Q1 2021 Apr 26, 2021	SELL	$4.52 - $7.8 $8,135 - $14,040	-1,800 Reduced 85.71%	300 $2,000
Q4 2020 Jan 25, 2021	BUY	$4.37 - $9.46 $9,177 - $19,866	2,100 New	2,100 $15,000
Q3 2020 Oct 20, 2020	SELL	$8.56 - $26.93 $80,575 - $253,492	-9,413 Closed	0 $0
Q2 2020 Jul 27, 2020	BUY	$21.21 - $31.55 $100,174 - $149,010	4,723 Added 100.7%	9,413 $259,000
Q3 2019 Oct 17, 2019	BUY	$29.87 - $42.22 $140,090 - $198,011	4,690 New	4,690 $145,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.